211 related articles for article (PubMed ID: 33385181)
1. Clinical Relevance of Isolated Lupus Anticoagulant Positivity in Patients with Thrombotic Antiphospholipid Syndrome.
Yin D; de Groot PG; Ninivaggi M; Devreese KMJ; de Laat B
Thromb Haemost; 2021 Sep; 121(9):1220-1227. PubMed ID: 33385181
[TBL] [Abstract][Full Text] [Related]
2. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
[TBL] [Abstract][Full Text] [Related]
3. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
Vandevelde A; Chayoua W; de Laat B; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
J Thromb Haemost; 2022 Sep; 20(9):2136-2150. PubMed ID: 35713971
[TBL] [Abstract][Full Text] [Related]
4. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
[TBL] [Abstract][Full Text] [Related]
5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies suggests strong thrombotic risk.
Lee JS; Gu J; Park HS; Yoo HJ; Kim HK
Clin Chem Lab Med; 2017 May; 55(6):882-889. PubMed ID: 28002027
[TBL] [Abstract][Full Text] [Related]
7. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of obstetric antiphospholipid syndrome: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
Vandevelde A; Gris JC; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
J Thromb Haemost; 2023 Jul; 21(7):1981-1994. PubMed ID: 37061133
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
Devreese KMJ; Linskens EA; Benoit D; Peperstraete H
J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
[TBL] [Abstract][Full Text] [Related]
9. Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies.
Ofer-Shiber S; Molad Y
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):261-6. PubMed ID: 25526601
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
11. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
[TBL] [Abstract][Full Text] [Related]
12. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
[TBL] [Abstract][Full Text] [Related]
13. IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis.
Kelchtermans H; Pelkmans L; de Laat B; Devreese KM
J Thromb Haemost; 2016 Aug; 14(8):1530-48. PubMed ID: 27279342
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies: evaluation of the thrombotic risk.
Devreese KM
Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
16. Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus.
Akhter E; Shums Z; Norman GL; Binder W; Fang H; Petri M
J Rheumatol; 2013 Mar; 40(3):282-6. PubMed ID: 23378459
[TBL] [Abstract][Full Text] [Related]
17. Detection of anti-domain I antibodies by chemiluminescence enables the identification of high-risk antiphospholipid syndrome patients: A multicenter multiplatform study.
Yin D; Chayoua W; Kelchtermans H; de Groot PG; Moore GW; Gris JC; Zuily S; Musial J; de Laat B; Devreese KMJ
J Thromb Haemost; 2020 Feb; 18(2):463-478. PubMed ID: 31749277
[TBL] [Abstract][Full Text] [Related]
18. Anti-phosphatidylserine/prothrombin complex antibodies (aPS/PT) increase the risk for thrombosis based on lupus anticoagulant positivity.
Zhang Y; Su Y; Guo H; Wang L; Li A; Wang C; Zhang J; Qiao R
Clin Biochem; 2023 Feb; 112():17-23. PubMed ID: 36535385
[TBL] [Abstract][Full Text] [Related]
19. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
[TBL] [Abstract][Full Text] [Related]
20. An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies.
De Laat B; Derksen RH; Reber G; Musial J; Swadzba J; Bozic B; Cucnik S; Regnault V; Forastiero R; Woodhams BJ; De Groot PG
J Thromb Haemost; 2011 Jan; 9(1):149-53. PubMed ID: 20874780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
